Skip to main content
. 2021 Mar 15;35(8):910–918. doi: 10.1177/0269881121991827

Figure 3.

Figure 3.

Meta-analysis of four double-blind RCTs including all comparisons (20–40 IU and 50 IU onabotulinumtoxinA).